Detalhe da pesquisa
1.
Interaction of Staphylococcus aureus and Acinetobacter baumannii during In Vitro ß-Lactam Exposure.
Antimicrob Agents Chemother
; 65(4)2021 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495215
2.
Capability of Enterococcus faecalis to shield Gram-negative pathogens from aminoglycoside exposure.
J Antimicrob Chemother
; 76(10): 2610-2614, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245262
3.
Inoculum effect of ß-lactam antibiotics.
J Antimicrob Chemother
; 74(10): 2825-2843, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31170287
4.
Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposure.
J Antimicrob Chemother
; 74(9): 2657-2665, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31219553
5.
Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.
Antimicrob Agents Chemother
; 61(4)2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096154
6.
High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model.
Antimicrob Agents Chemother
; 61(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052852
7.
Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniae.
J Antimicrob Chemother
; 72(7): 1985-1990, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444224
8.
High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii.
J Antimicrob Chemother
; 72(1): 153-165, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27634916
9.
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
J Antimicrob Chemother
; 72(5): 1415-1420, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28333347
10.
Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined ß-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of ß-Lactam-ß-Lactamase Inhibitor Combinations.
Antimicrob Agents Chemother
; 60(4): 1967-73, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26729494
11.
Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
Antimicrob Agents Chemother
; 60(7): 3913-20, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067330
12.
Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure.
Antimicrob Agents Chemother
; 60(3): 1584-91, 2015 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26711763
13.
Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotype.
Antimicrob Agents Chemother
; 59(2): 1347-51, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25451045
14.
Escaping ESKAPE resistance: in vitro and in silico studies of multifunctional carbamimidoyl-tethered indoles against antibiotic-resistant bacteria.
R Soc Open Sci
; 10(4): 230020, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090961
15.
Small Molecules Incorporating Privileged Amidine Moiety as Potential Hits Combating Antibiotic-Resistant Bacteria.
Pharmaceuticals (Basel)
; 16(7)2023 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37513951
16.
Relative Abundance and Detection of Pseudomonas aeruginosa from Chronic Wound Infections Globally.
Microorganisms
; 11(5)2023 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317184
17.
Research priorities towards precision antibiotic therapy to improve patient care.
Lancet Microbe
; 3(10): e795-e802, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777386
18.
Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?
Antibiotics (Basel)
; 10(6)2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34071451
19.
A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy.
Diagn Microbiol Infect Dis
; 98(1): 115080, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32619895
20.
Shifting Gears: The Future of Polymyxin Antibiotics.
Antibiotics (Basel)
; 8(2)2019 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31013818